Indacaterol Gronethium Bromide Inhalation Powder Aerosol Capsules for Indacaterol Gronethium Bromide Inhalation Powder Aerosol Capsules, and Budigraf i.e. Budigraf Aerosol, both can effectively alleviate dyspnea caused by COPD, the effect varies from person to person, there is no absolute good or bad distinction. Indacaterol Gronethium Bromide Inhalation Powder Aerosol Capsules is a compound preparation, mainly containing indacaterol maleate and gronethium bromide as two ingredients, which has a diastolic effect on the bronchial tubes, and can effectively alleviate dyspnea caused by chronic obstructive pulmonary disease. Adverse reactions such as chest pain, peripheral edema, fatigue, cough, headache and so on may occur when using this medicine, and it is forbidden for those who are allergic to this medicine. Budigraf Inhalation Aerosol is also a combination of budesonide, griseofulvin bromide and formoterol fumarate, which is used for the maintenance treatment of chronic obstructive pulmonary disease. Adverse effects of the drug can include oral infections, palpitations and cough. It is contraindicated in people who are allergic to the drug. Formoterol and Indacaterol are similar in effect, both have the effect of having diastolic bronchial smooth muscle and relieving bronchospasm; both contain glonidazide, a long-acting acetylcholine receptor antagonist that inhibits bronchial smooth muscle receptors, thereby dilating the airways. Budesonide is a glucocorticoid that has a dose-dependent anti-inflammatory effect with use, although it reduces COPD symptoms and minimizes acute exacerbations of COPD. Indacaterol Glonazepam Inhalation Powder Mist and Budesonide vary from person to person, different people have different sensitivities to the drug, and the therapeutic effect will be different, suffering from COPD it is recommended to visit a regular hospital, and a professional doctor to formulate an appropriate treatment plan.